Michelle Holloway
Child & Adolescent Psychiatry · Oklahoma City, OKNPI 1235166364
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,419 of the $47,478 with a category attached, or 78.8%. Noven Pharmaceuticals, Inc. accounts for 84.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $40,870 and has fallen 88.0% since, to $4,894 in 2025. Among child & adolescent psychiatry clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $277.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noven Pharmaceuticals, Inc.$40K
- Noven Therapeutics, LLC$5K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$446
- Supernus Pharmaceuticals, Inc.$229
- Bausch Health US, LLC$203
- plus $823 from 10 others
What the payments were for
- Speaking & faculty fees$37,41979%
- Travel & lodging$5,87212%
- Food & beverage$4,1799%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noven Pharmaceuticals, Inc. | 37 | $39,976 |
| Noven Therapeutics, LLC | 26 | $4,652 |
| Otsuka America Pharmaceutical, Inc. | 44 | $1,150 |
| AbbVie | 21 | $446 |
| Supernus Pharmaceuticals, Inc. | 6 | $229 |
| Bausch Health US, LLC | 10 | $203 |
| Corium, LLC | 4 | $200 |
| Johnson & Johnson | 6 | $192 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| Neurocrine Biosciences, Inc. | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,478 in reported general payments places this provider in the 95th percentile of 34 child & adolescent psychiatry providers in Oklahoma.
See all child & adolescent psychiatry providers in Oklahoma →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 31 | $133,381 |
| Lurasidone Hcl | 49 | $15,039 |
| Lisdexamfetamine Dimesylate | 24 | $4,826 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 89 | $3,826 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 52 | $3,021 |
| Aripiprazole | 81 | $2,874 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 67 | $2,219 |
| Ziprasidone Hcl | 37 | $1,878 |
| Atomoxetine Hcl | 18 | $1,539 |
| Quetiapine Fumarate | 88 | $1,236 |
| Doxepin Hcl | 31 | $1,191 |
| Bupropion XlBupropion Hcl | 93 | $1,088 |
| Lamotrigine | 119 | $1,083 |
| Olanzapine | 56 | $1,042 |
| Duloxetine Hcl | 70 | $996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $95 | $133,38131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 34 child & adolescent psychiatry providers in Oklahoma.
Other child & adolescent psychiatry in Oklahoma City
- Drew DawsonOklahoma City$2K
- Geetika VermaOklahoma City$1K
- Tayyaba AliOklahoma City$587
- Heather GeisOklahoma City$301
- Ayesha SattarOklahoma City$171
- Ethan LindseyOklahoma City$115
- Brent BellOklahoma City$92
- Betsy ShadidOklahoma City$38
- Khalil SalibaTulsa$27K
- Chariny HerringTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.